...Ltd. $39.2 Precision Biopsy LLC $33.6 Oxford Pharmascience Group plc (LSE:OXP) $31.5 Abzena plc $31.3 SciFluor...

...Ltd. $39.2 Precision Biopsy LLC $33.6 Oxford Pharmascience Group plc (LSE:OXP) $31.5 Abzena plc $31.3 SciFluor...

...pressure (IOP). Secondary endpoints include mean change in anatomic center subfield thickness and macular volume. SciFluor...
...small molecule integrin antagonist to treat diabetic macular edema (DME) (see BioCentury, Oct. 6 ). SciFluor...
...center subfield thickness and macular volume Status: Phase I/II data Milestone: NA Chris Lieu SF0166 Topical Ophthalmic Solution SciFluor...

...macular volume, best corrected visual acuity (BCVA), slit-lamp findings, fundus assessment and intraocular pressure (IOP). SciFluor...
...I/II trial of SF0166 to treat wet age-related macular degeneration (AMD) are expected this quarter. SciFluor...
...fundus assessment and intraocular pressure (IOP) Status: Phase I/II data Milestone: NA Jennie Walters SF0166 Topical Ophthalmic Solution SciFluor...

...levels of twice-daily SF0166 Topical Ophthalmic Solution for 28 days in up to 40 patients. SciFluor...

...is a potassium channel Kv7.2 (KCNQ2) and KCNQ3 modulator and a fluorinated derivative of retigabine. SciFluor...

...Allied Minds plc (LSE:ALM) subsidiary SciFluor Life Sciences LLC (Cambridge, Mass.) raised $30 million in an...
...investors Invesco Asset Management and Woodford Investment Management. Allied Minds and affiliated investors also participated. SciFluor...
...markets ezogabin as Potiga in the U.S. and Trobalt in the EU to treat epilepsy. SciFluor...

...Ontario, and Mina Bissell, professor of cell and molecular biology at Lawrence Berkeley National Laboratory SciFluor...

...prole compared to Potiga ezogabine. Data were presented at the International Epilepsy meeting in Montreal. SciFluor...
...potassium channel opener and potentiator of GABA, as adjunctive treatment of partial-onset seizures in adults. SciFluor...